Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2020 | ctDNA: bladder cancer management & assessment

Alexander Wyatt, PhD, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada, discusses the use of circulating tumor DNA (ctDNA) in the management and risk assessment of muscle invasive bladder cancer. Specifically, Dr Wyatt gives and overview of how ctDNA analysis can allow for the characterization of disease biology on an extremely deep level and lead to molecularly driven trials. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter